Industry News

Medical Device Industry News

Teva Pharmaceuticals and Sanofi Announce Accelerated Timeline for Anti-TL1A Phase 2b Program in Patients with Inflammatory Bowel Disease

July 25th, 2024|Medical Device News Magazine, Uncategorized|

Patient enrollment in the RELIEVE UCCD (ulcerative colitis and Crohn’s disease) Phase 2b trial has completed early due to significant acceleration in patient recruitment. As a result, Teva Pharmaceuticals and Sanofi now anticipate having topline

The Crossroads of a Revolution: Medical Device Design Meets Disruption | By Steve Levine, Senior Director, Virtual Human Modeling, Dassault Systèmes

July 25th, 2024|Medical Device News Magazine|

Explore how the intersection of medical device design and disruptive technologies is reshaping the healthcare industry. Discover how new players armed with AI-driven devices and advanced manufacturing tools are pushing boundaries and revolutionizing the future